Discontinued use of mycophenolate mofetil and graft loss in heart transplant recipients.

被引:0
|
作者
Legorreta, Antonio P.
Gilmore, Amanda G.
Marehbian, Josh
Machnicki, Gerardo
机构
[1] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
[2] Hlth Benchmarks Inc, Woodland Hills, CA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1080
引用
收藏
页码:425 / 425
页数:1
相关论文
共 50 条
  • [31] Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients
    Weigel, G
    Griesmacher, A
    Karimi, A
    Zuckermann, AO
    Grimm, M
    Mueller, MM
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (10): : 1074 - 1079
  • [32] Graft loss and costs following gastrointestinal (GI) complications and GI medication use in renal transplant recipients using mycophenolate mofetil (MMF)
    Lalla, Anjana
    Gilmore, Amanda
    Machnicki, Gerardo
    Legorreta, Antonio
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 440 - 440
  • [33] Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients.
    Mitchell, J.
    Chiang, T. P.
    Alejo, J.
    Chang, A.
    Abedon, A.
    Avery, R.
    Tobian, A.
    Massie, A.
    Levan, M.
    Warren, D.
    Garonzik-Wang, J.
    Segev, D.
    Werbel, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 440 - 440
  • [34] Frailty, Mycophenolate Reduction, and Graft Loss in Kidney Transplant Recipients
    McAdams-DeMarco, Mara A.
    Law, Andrew
    Tan, Jingwen
    Delp, Cassandra
    King, Elizabeth A.
    Orandi, Babak
    Salter, Megan
    Alachkar, Nada
    Desai, Niraj
    Grams, Morgan
    Walston, Jeremy
    Segev, Dorry L.
    TRANSPLANTATION, 2015, 99 (04) : 805 - 810
  • [35] Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients
    Johnson, DW
    Nicol, DL
    Preston, JM
    Brown, AM
    Hawley, CM
    Campbell, SB
    Wall, D
    Griffin, AD
    Isbel, NM
    TRANSPLANTATION, 2003, 76 (03) : 619 - 619
  • [36] Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients
    Sureshkumar, KK
    Nghiem, DD
    TRANSPLANTATION, 2003, 76 (02) : 441 - 442
  • [37] Safety of Stimulant Use in Heart Transplant Recipients.
    Callaghan, K.
    Norris, M.
    Sammons, C.
    Fallah, T.
    Eldabbas, H.
    Liu, X.
    Wang, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 840 - 841
  • [38] Measurement of mycophenolate mofetil effect in transplant recipients
    Ogawa, N
    Nagashima, N
    Nakamura, M
    Shalabi, A
    Maley, WR
    Burdick, JF
    TRANSPLANTATION, 2001, 72 (03) : 422 - 427
  • [39] Tolerability of mycophenolate mofetil in organ transplant recipients
    Schweizer, RT
    Meisterling, LD
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2309 - 2309
  • [40] Mycophenolate mofetil monotherapy in liver transplant recipients
    Kriss, Michael
    Sotil, Eva U.
    Abecassis, Michael
    Welti, Mary
    Levitsky, Josh
    CLINICAL TRANSPLANTATION, 2011, 25 (06) : E639 - E646